Best Fit Profiles
- metabolic and endocrine support protocols
Insulin sensitivity and endocrine-metabolic support
Myo-Inositol
Best evidence is in insulin-resistant and PCOS-like profiles, where myo-inositol can improve insulin markers and selected hormone-related outcomes.
Evidence Level B
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Modest glucose and hormonal-metabolic support
- Safety
- Low Risk
Best used within a full nutrition and activity plan rather than as standalone therapy.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 2-4 g
- Timing
- Once or twice daily
- Protocol Duration in Studies
- 8-24 weeks in endocrine-metabolic studies
Dose can be split to improve GI comfort.